2024-03-14 02:20:00
“Now it’s up to us to play, but we will have to play a hyper-collective game! » declared the regional president this Wednesday March 13 in Dijon
This Wednesday, March 13, 2024, the Regional Council of Burgundy-Franche-Comté, in Dijon, hosted the Biotherapies and Bioproduction Conference, a major event dedicated to the future of medicine. This gathering of key players in the field aims to define an ambitious roadmap for the region, emphasizing innovation and bioproduction in the medical field.
The event was introduced by Franck Robine, prefect of the Burgundy-Franche-Comté region and Côte-d’Or, as well as by Marie-Guite Dufay, president of the Burgundy-Franche-Comté region. Several speakers spoke, including Anne Jouvenceau from the Health Innovation Agency, Nicolas Soret, vice-president of the region in charge of the economy, Laetitia Martinez, vice-president of the region in charge of higher education and Nicolas Paris. More than a hundred participants, including researchers, clinicians, manufacturers and support structures, responded to the Region’s call. Their objective is to share their perspectives, their experiences and to discuss the challenges to be met in the fields of biotherapies and bioproduction, in order to nourish collective reflection. This collaboration aims to develop a strategic roadmap aimed at placing the region on the map of national and international hubs in this crucial area of medicine.
A sector of the future The President of the Region Marie-Guite Dufay expressed her confidence in this new health sector: “I am convinced that biotherapies and bioproduction represent a regional sector of the future. In Burgundy-Franche-Comté, it is up to us to play a hyper-collective game. » and continues “I would like that throughout this process that I am launching today, we always keep in mind that it is not this or that interest that must prevail, but always the interest of the patient.” A need for industrial sovereignty Regional prefect Franck Robine affirmed the support of the State: “This is a subject on which the State fully supports the region in its approach to developing the roadmap for biotherapies, because our industrial sovereignty is at stake, particularly in terms of health. »
But also raised a problem to be resolved:
“The Covid crisis was obviously a crisis revealing our dependence in terms of health. (…) One of the consequences and one of the lessons learned from the Covid crisis is that our country and Europe in general must equip itself with a completely sovereign health industry in matter. » “The region has very solid industrial bases to become a major player in the health sector. We must all be united. Whether it is research or production, yes we believe in it, and the State will be at your side. »A regional industrial and scientific heritageBiotherapies, such as vaccines and innovative cell therapies, represent the future of medicine. Biomanufacturing is the key to producing these biomedicines in an efficient and scalable manner.
The Burgundy-Franche-Comté region, with its scientific and industrial heritage, is positioned to play a leading role in this therapeutic and economic revolution. With a network of innovative SMEs, efficient research establishments and technology transfer players, the region benefits from an environment conducive to the development of the medicine of the future. The regional health sector has nearly 500 establishments and 13,000 employees, illustrating the importance of this sector for the regional economy. A new strategy for new challenges In a constantly evolving field, the challenges are numerous. International competition is fierce, but the region is determined to play a major role in the development of biotherapies and bioproduction. The Biotherapies and Bioproduction Conference represents a crucial step in the construction of a strong and competitive regional sector.
An ambitious new strategy was unveiled at the event, focused on innovation and bioproduction in the medical field. This strategy articulates four main axes aimed at catalyzing innovation, training in essential skills and developing the industrial tools necessary to support innovative companies. This initiative is part of the France 2030 national strategy, which aims to make France the European leader in health innovation. Burgundy-Franche-Comté has undeniable assets in this area, notably know-how and a highly qualified workforce, inherited from its industrial tradition.
In conclusion, the Conference on Biotherapies and Bioproduction marks an important step in the commitment of the Burgundy-Franche-Comté region to the future of medicine. This ambitious initiative aims to position the region as a major player in the field of biotherapies and bioproduction, thus contributing to improving the health of patients nationally and internationally.
Manon Bollery
1710386798
#BOURGOGNEFRANCHECOMTÉ #region #committed #future #medicine #biotherapy
